Intech Biopharm 

TWD27.20
4
-TWD0.30-1.09% 05:30 Today

Statistics

Day High
27.6
Day Low
26.55
52W High
42.44
52W Low
22.79
Volume
82,349
Avg. Volume
94,123
Mkt Cap
4.85B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-925.63%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
39.78MRevenue
-368.21MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 6461.TWO. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Intech Biopharm Corporation is a pharmaceutical company dedicated to the global development and production of generic medications for respiratory conditions. Their portfolio includes innovative drug delivery systems, such as iLEF (inhaled low ethanol formulation), a proprietary metered dose inhaler platform specifically engineered for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Additionally, they offer a dry powder inhaler (DPI) technology, which utilizes blisters and capsules for precise dosage. These therapeutic solutions are marketed under various brand names, including SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011. Established in Taipei, Taiwan, in 2010, the company maintains its headquarters in the city.
Show More
CEO
Wei Hsiu Wu
Employees
96
Country
Taiwan
ISIN
TW0006461007

Listings

0 Comments

Share your thoughts

FAQs

What is Intech Biopharm stock price today?▼
The current price of 6461.TWO is TWD27.20 TWD — it has decreased by -1.09% in the past 24 hours. Watch Intech Biopharm stock price performance more closely on the chart.
What is Intech Biopharm stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Intech Biopharm stocks are traded under the ticker 6461.TWO.
Is Intech Biopharm stock price growing?▼
6461.TWO stock has risen by +3.42% compared to the previous week, the month change is a +2.84% rise, over the last year Intech Biopharm has showed a +64.35% increase.
What is Intech Biopharm market cap?▼
Today Intech Biopharm has the market capitalization of 4.85B
What is Intech Biopharm revenue for the last year?▼
Intech Biopharm revenue for the last year amounts to 39.78M TWD.
What is Intech Biopharm net income for the last year?▼
6461.TWO net income for the last year is -368.21M TWD.
How many employees does Intech Biopharm have?▼
As of November 3, 2026, the company has 96 employees.
In which sector is Intech Biopharm located?▼
Intech Biopharm operates in the Health & Wellness sector.
When did Intech Biopharm complete a stock split?▼
Intech Biopharm has not had any recent stock splits.
Where is Intech Biopharm headquartered?▼
Intech Biopharm is headquartered in Taipei, Taiwan.